Appleton, 1998109
| • NHSBSP guidelines, 1991-1992 | • Royal College of Pathologists Working Group.
Pathology reporting in breast cancer screening. Sheffield:
NHSBSP Publications, 1989 |
|
Bernhard, 1997110
| • IBCSG form for assessing impact of adjuvant
therapy on QOL | • Hürny C, Bernhard J, Gerber RD et al. Quality of
life measures for patients receiving adjuvant therapy for breast
cancer: An International Trial. The International Breast Cancer
Study Group. Eur J Cancer 1992;28:118–24 |
| • LASA scales (physical well-being; mood;
appetite) | • Coates A, Fisher Dillenbeck CF, McNeil DR et al.
On the receiving end II. Linear analogue self-assessment (LASA)
in evaluation of aspects of the quality of life of cancer
patients receiving chemotherapy. Eur J Cancer Clin Oncol 1983;
19: 1633–7 |
|
Bickell, 2000111
| • Mount Sinai Health Final Guidelines for Stage I
& II BC treatment, 1994-1995 | • Bickell NA, Aufses AH Jr, Chassin MR. Engaging
clinicians in a QI strategy for early-stage breast cancer
treatment. Qual Manag Health Care 1998; 6:63–68 |
|
Bickell, 2003112
| • Mount Sinai Health Final Guidelines for Stage
I–II BC treatment, 1994-1995 | • Bickell NA, Aufses AH Jr, Chassin MR. Engaging
clinicians in a QI strategy for early-stage breast cancer
treatment. Qual Manag Health Care 1998; 6:63–68 |
|
Bower, 2000113
| • RAND 36-item Health Survey 1.0 | • Hays RD, Sherbourne CD, Mazel RM. The RAND
36-item Health Survey 1.0. Health Econ 1993; 2:217–227 |
| | • Ware JE Jr, Sherbourne CD: A 36-item Short Form
Health Survey (SF-36): I. Conceptual framework and item
selection. Med Care 1992; 30:473–83 |
|
Brenin, 1999114
| • NIH Consensus Development Conference, 1990 | • Treatment of early stage breast cancer. NIH
Consensus Statement. 1990; 8:1–19 |
|
Cheung, 1999116
| • BASO guidelines, 1995 | • Breast Surgeons Group of the British Association
of Surgical Oncology. Guidelines for Surgeons in the management
of symptomatic breast disease in the United Kingdom. Eur J Sur
Oncol 1995; 21 (Suppl. A) |
|
Chie,1999117
| • SF-36 Chinese version | • New England Medical Center Hospital: IQOLA SF-36
Taiwan Standard version 1.0. Boston: The Health Institute, New
England Medical Center, 1996 |
| • EORTC-QLQ-C30 | • EORTC Quality of Life Study Group: Questionnaire
of the Department of Obstetrics and Gynecology, Hong Kong
University (EORTC QLQ-C30 version 2.0). Brussels: Quality of
Life Unit, EORTC Data Center, 1997 |
|
Christensen, 2002118
| • European Guidelines for Quality Assurance in
Mammography screening, 1996 -Guidelines for cytology procedures
and reporting in BC screening, 1993 | • European Guidelines for Quality Assurance in
Mammography Screening. 2nd ed. Brussels: European Commission,
1996 |
| | • Guidelines for Cytology Procedures and reporting
in Breast Cancer Screening. Sheffield: Cytology Sub-group of the
National Coordinating Committee for Breast Screening Pathology,
1993 |
|
Cochrane, 1997119
| • NHSBSP breast referral guidelines, 1995 | • Austoker J, Mansel R, Baum M et al. Guidelines
for the Referral of Patients with Breast Problems. NHS Breast
Screening Programme on behalf of the Department of Health
Advisory Committee on Breast Screening, 1995 |
|
Cornfeld, 2001120
| • NCCN Guidelines, 1999 | • Carlson RW. (Panel Chair) for NCCN Breast Cancer
Practice Guidelines Panel Members. Update: NCCN Practice
Guidelines for the Treatment of Breast Cancer. Oncology. 1999;
13:187–218 |
|
Craft, 2000121
| • NHMRC CPG for the management of early BC,
1995 | • National Health and Medical Research Council.
Clinical Practice Guidelines. The management of early breast
cancer. Canberra: NHMRC, 1995 |
|
DeMichele, 2003122
| • St. Gallen Consensus Conference, 1992-1995
(update) | • Glick J, Gerber R, Goldhirsch A et al. Meeting
Highlights: adjuvant therapy for primary breast cancer. J Natl
Cancer Inst 1992;84:1479–1485 |
| | • Goldhirsch A, Glick J, Gerber R et al. Meeting
Highlights: international consensus panel on the treatment of
primary breast cancer. J Natl Cancer Inst 1998;90:1601–8 |
|
Du, 2001124
| • NIH Consensus Conference Development, 1990 | • NIH Consensus Conference. Adjuvant chemotherapy
for breast cancer. JAMA 1985;254:3461–3 |
| | • NIH Consensus Conference. Treatment of
early-stage breast cancer. JAMA 1991;265:391–5 |
|
Du, 2003125
| • NIH Consensus Development Conference, 1990 | • NIH Consensus Conference. Adjuvant chemotherapy
for breast cancer. JAMA 1985;254:3461–3 |
| | • NIH Consensus Conference. Treatment of
early-stage breast cancer. JAMA 1991;265:391–5 |
|
Edge, 2002126
| • NIH Consensus Development Conference 1990 | • Early stage breast cancer: consensus statement.
NIH Consensus Development Conference, June 18–21, 1990. cancer
Treat Res 1992;60:383–393 |
| • Steering committee on CPGs for the care &
treatment of BC, CARO | • The Steering Committee on Clinical Practice
Guidelines for the care and treatment of breast cancer. Axillary
dissection. Canadian Association of Radiation Oncologists. CMAJ
1998;158(Suppl 3):S22–S26 |
|
Engel, 2002127
| • NIH Consensus Development Conference, 1990 | • Lazovich D,
Solomon CC, Thomas DB et al. Breast Conservation therapy in
the United States following the 1990 NIH Consensus
Development Conference on the treatment of patients with
early stage invasive breast carcinoma. Cancer
1999;86:628–37
|
| • St. Gallen's Consensus for adjuvant systemic
therapy, 1995-1998 (update) | • Goldhirsch A, Glick J, Gerber R et al. Meeting
Highlights: international consensus panel on the treatment of
primary breast cancer. J Natl Cancer Inst 1998;90:1601–8 |
|
Foroudi, 2002128
| • NCI's physician Data Query treatment Options | • National Cancer Institute. CancerNet: A service
of the National Cancer Institute: PDQ Cancer Information
Summaries: Treatment. Monograph on line. Accessed September
2001. url: http://cancernet.nci.nih.gov/pdq/pdq_treatment.shtml. |
| • Cancer Care Ontario Clinical Practice
Guidelines | • Cancer Care Ontario Practice Guidelines
Initiative. Breast |
| • Clinical Practice Guidelines for the Care and
Treatment of Breast Cancer: A Canadian Consensus Document | • Cancer clinical practice guidelines. Monograph on
line. Accessed September 2001. url:http://hiru.mcmaster.ca/ccopgi/brecpg.html. |
| • NIH Consensus Conference on the Treatment of
Early Stage Breast Cancer | • Anonymous. Clinical practice guidelines for the
care and treatment of breast cancer: A Canadian consensus
document.Can Med Assoc J 1998;158(Suppl. 3):S1–S83. |
| • National Comprehensive Cancer Network Clinical
Practice Guidelines | • Anonymous. Early stage breast cancer—NIH
consensus conference. JAMA 1991;265:391–395. |
| • British Columbia Cancer Agency's Cancer
Management Manual | • Carlson RW, Goldstein LJ, Gradishar WJ, et al.
Update of the NCCN guidelines for treatment of breast cancer.
Oncology 1997;11:199–220. |
| • Diseases of the Breast | • British Columbia Cancer Agency. Cancer management
manual. Monograph on line. Accessed December 1999. url:
http://www.bccancer.bc.ca/pg_g_04.asp?PageID _
1109&Parent-ID _ 4/. |
| • American Colleges of Radiology, Surgery, and
Pathology's Standards for Breast Conservation Treatment | • Harris DM, Lippman ME, Morrow M, et al. Diseases
of the breast. 2nd ed. Philadelphia: Lippincott Williams
& Wilkins; 2000. |
| • American College of Radiology's Appropriateness
Criteria | • Winchester DP, Cox JD. Standards for breast
conservation treatment. Cancer 1992;42:134–163. |
| • Scottish Intercollegiate guidelines Network's
National Clinical Guidelines | • American College of Radiology Task Force on
Appropriateness Criteria. Appropriateness criteria for imaging
and treatment decisions in radiation oncology. Reston, VA:
American College of Radiology; 1999. |
| • UK Royal College of Radiology's Clinical Oncology
Information Network Guidelines | • Scottish Intercollegiate Guidelines Network.
Management of breast cancer. Monograph on line. Accessed
September 2001. url:http://www.show.scot.nhs.uk/sign/pdf/sign29.pdf
|
| • British Association of Surgical Oncology's
Symptomatic Breast Disease Guidelines | • Royal College of Radiologists Clinical Oncology
Information Network (COIN). Guidelines on the non-surgical
management of breast cancer. Monograph on line. Accessed
September 2001. url:http://www.rcr.ac.uk/breast.pdf. |
| | • BASO Breast Surgeons Group. The guidelines for
surgeons in the management of symptomatic breast disease. Eur J
Surg Oncol 1996;22:465–476. |
|
Frazer, 1998129
| • 39-item Guttman scaled HSQ Questionnaire
form | • Radosevich DM, Wetzler H, Wilson SM. Health
Status Questionnaire (HSQ) 2.0: Scoring Comparisons and
Reference Data. Bloomington MN: Health Outcomes Institute, 1995,
1–70 |
|
Guadagnoli, 1997130
| • EBCTCG meta-analysis, 1992 | • Early Breast Cancer Trialists' Collaborative
Group: Systematic treatment of early breast cancer by hormonal,
cytotoxic, or immune therapy: 133 randomized trials involving
31,000 recurrences and 34,000 deaths among 75,000 women. Part 2.
Lancet 1992;339:71–85 |
|
Guadagnoli, 1998a131
| • NIH Consensus Development Conference, 1990 | • NIH Consensus Conference. Treatment of
early-stage breast cancer. JAMA 1991;265:391–5 |
|
Guadagnoli, 1998b132
| • NIH Consensus Development Conference, 1990 | • NIH Consensus Conference. Treatment of
early-stage breast cancer. JAMA 1991;265:391–5 |
|
Haas, 2000133
| • Harvard Risk Management Foundation guidelines,
1995 | • Smith B. Algorithms for management of common
breast complaints. Forum: Harvard Risk Management Foundation.
July 1995: 1–5 |
|
Harlan, 2002134
| • NIH Consensus Development Conference, 1990 | • NIH Consensus Conference. Treatment of
early-stage breast cancer. JAMA 1991;265:391–5 |
|
Hassey Dow, 2000123
| • Ferrans Quality-of-Life Index- cancer version
(QLI) 1990 | • Ferrans CE (1990). Development of a
quality-of-life index for patients with Cancer. Oncol Nurs
Forum, 17(Suppl.3), 15–19 |
|
Hebert-Croteau, 1999135
| • NIH Consensus Development Conference, 1990 | • NIH Consensus Conference. Treatment of
early-stage breast cancer. JAMA 1991;265:391–5 |
|
Hislop, 2003136
| • BCCA cancer treatment policy manual, 1995 | • Breast Tumor Group. In: Cancer Treatment
Policies, 3rd ed. Vancouver, BC: Cancer Control Agency of
British Columbia, 1988 |
|
Imperato, 2002137
| • CAP & ADASP guidelines 1997/2000
(update) | • Henson DE, Oberman HA, Hutter RVP et al. Practice
protocol for the examination of specimens removed from patients
with cancer of the breast. Publication of the Cancer Committee,
College of American Pathologists. Arch Pathol Lab Med
1997;121:27 |
| | • Fechner RE, Kempson RL, Livolsi VA et al.
Recommendations for the reporting of breast carcinoma.
Association of Directors of Anatomic and Surgical Pathology. Am
J Clin Pathol 1995;104:614 |
| | • Fitzgibbons PL, Connolly JL, Page DL. Updated
protocol for the examination of specimens from patients with
carcinoma of the breast. A basis for checklists. Arch Pathol Lab
Med 2000;124:966 |
|
Jackson, 1999138
| • BCCA guidelines, 1986, update in 1989 &
1993 | • Breast Tumor Group. In: Cancer Treatment
Policies, 5th ed. Vancouver, BC: Cancer Control Agency of
British Columbia, 1995 |
| | • BC Cancer Agency. Division of Radiation Oncology.
Radiotherapy treatment techniques: breast and prostate sections.
Vancouver, BC: Cancer Agency. Division of Radiation Oncology;
1981-1996 |
|
Jansen, 2000139
| • Rotterdam Symptom Checklist (RSCL) | • De Haes JC, Olschewski M. Quality of life
assessment in cross-cultural context: Use of Rotterdam Symptom
Checklist in a multinational randomized trial comparing CMF and
Zoladex (Goserlin) treatment in early breast cancer. Ann Oncol
1998;9:745–750 |
| • SF-36 | • Ware JE, Sherbourne CD. The MOS 36-item
Short-Form health status survey (SF-36):1. Conceptual framework
and item selection. Med Care 1992;30:473–483 |
|
Keating, 2001140
| • NIH Consensus Development Conference, 1990 | • National Institutes of Health Consensus
Development Conference Statement. Treatment of early stage
breast cancer. Paper presented at: NIH Consensus Development
Conference; June 18–21, 1990; Bethesda, MD |
|
Khawaja, 2001141
| • BASO breast group recommendations 1995/1998
(update) | • BASO Breast Surgeons Group. The guidelines for
surgeons in the management of symptomatic breast disease. Eur J
Surg Oncol 1996;22:465–476 |
| | • BASO Breast Surgeons Group. The guidelines for
surgeons in the management of symptomatic breast disease. Eur J
Surg Oncol 1998;24:464–476 |
|
Legorreta, 2000144
| • NIH Consensus Development Conference, 1990 | • NIH Consensus Conference. Treatment of
early-stage breast cancer. JAMA 1991;265:391–5 |
|
Lazovich, 1997142
| • NIH Consensus Development Conference, 1990 | • NIH Consensus Conference. Treatment of
early-stage breast cancer. JAMA 1991;265:391–5 |
|
Lazovich, 1999143
| • NIH Consensus Development Conference, 1990 | • NIH Consensus Conference. Treatment of
early-stage breast cancer. JAMA 1991;265:391–5 |
|
Mandelblatt, 2001145
| • NIH Consensus Development Conference, 1990 | • NIH Consensus Conference. Treatment of
early-stage breast cancer. JAMA 1991;265:391–5 |
|
Mandelblatt, 2002146
| • NIH Consensus Development Conference, 1990 | • NIH Consensus Conference. Treatment of
early-stage breast cancer. JAMA 1991;265:391–5 |
|
McCarthy, 1997147
| • Quality assurance guidelines (NHSBSP), 1994 | • Quality Assurance Guidelines for Surgeons in
Breast Cancer Screening. NHSBSP Publication No 20,
1994:1–45 |
|
McGlynn, 2003173
| • From observational studies and expert opinion, to
randomized controlled trials | • Not reported |
|
Molenaar, 2001148
| • IKA/IKST: Working group on Mamma Carcinoma;
treatment guidelines; the Netherlands; Comprehensive Cancer
Center, 1995 | • IKA/IKST: Working group on Mamma Carcinoma:
IKA/IKST treatment guidelines Mamma Carcinoma. Amsterdam, the
Netherlands; Comprehensive Cancer Center, 1995 |
| • Generic QOL MOS20 | • Kempen GI. Assessment of health status among the
elderly; an application of a Dutch version of MOS-survey.
Tijdschr Gerontol Geriatr 1992;23:132–140 |
| • EORTC QLQ-BR23 | • Saprangers MAG, Groenvold M, Arraras JI et al.
The European Organization Research and Treatment of Cancer
Breast Cancer-specific Quality-of-Life Questionnaire Module:
First results from a three-country field study. J Clin Oncol
1996;14:2756–2768 |
|
Mor, 1994149
| • MHI-5 | • Stewart AL, Hays RD, Ware JE Jr: The MOS short
form general health survey: reliability and validity in patient
populations. Med Care 1981;26:724 |
|
Mor, 2000150
| • NCI Consensus Conference for surgeons, 1993 | • Published in this article (Ref 150) |
|
Morrow, 2001;151
| • ACOS, ACR, CAP, SSO guidelines, 1992 | • Winchester DP, Cox JD: Standards for
breast-conservation treatment. CA Cancer J Clin
1992;42:134–176 |
White, 2003166
| | |
|
Nattinger, 2000152
| • NIH Consensus Development Conference, 1990 | • National Institutes of Health Consensus
Development Conference Statement. Treatment of early stage
breast cancer. Paper presented at: NIH Consensus Development
Conference; June 18–21, 1990; Bethesda, MD |
|
Northouse, 1999115
| • BC specific version of 37-item scale FACT-B,
1993 | • Cella DF, Tulsky DS, Gray G et al. The Functional
Assessment of Cancer Therapy Scale: Development and validation
of the general measure. J Clin Oncol 1993; 11:570–579 |
|
Osoba, 1999153
| • Self-administered EORTC core QOLQ- C30 (30
items) | • Fayers P, Aaronson N, Bjordal K et al. EORTC
QLQ-C30 Scoring Manual. Brussels, Belgium, Quality of Life Unit,
EORTC Data Centre, 1995 |
|
Ottevanger, 2002154
| • Regional Guidelines (CCCE) (year: NR) | • Not published |
|
Palazzi, 2002155
| • SGCC, 1995 | • Goldhirsch A, Wood WC, Senn HJ et al. Meeting
Highlights: international consensus panel on the treatment of
primary breast cancer. J Natl Cancer Inst 1995;87:1441–5 |
|
Perez, 2001156
| • HRQOL scale: Spitzer QLI & uniscale
questionnaire (scale 0–100) | • Spitzer WO, Dobson AJ, Hall J, et al. Measuring
the quality of life of cancer patients. J Chron Dis 1981; 34:
585–597 |
| • TTO | |
|
Ray-Coquard, 1997157,
158
| • Regional CPG, 1993; implemented, 1994 | • Not reported |
|
Ray-Coquard, 2002159
| • Regional (ONCORA) CPG, 1995 | • Not reported |
|
Sauven, 2003160
| • NHSBSP surgical standards,1992 | • NHSBSP. Quality Assurance Guidelines for Surgeons
in Breast Cancer Screening. Publication no. 20; NHSBSP:
Sheffield, 1992 |
|
Sawka, 1997161
| • Guidelines of British Columbia, 1991 | • Olivotto I, Bajdik C, Plenderleith I et al.
Adjuvant systemic therapy and survival from breast cancer. N
Engl J Med 1994; 330:805–10 |
| | • Browman GP, Levine MN, Mohide E et al. The
practice guidelines development and implementation. J Clin Oncol
1995;13:502–12 |
|
Shank, 2000162
| • ACR, ACS, CAP & SSO standards for breast
conservation treatment, 1992 | • Winchester DP, Cox JD: Standards for
breast-conservation treatment. CA Cancer J Clin
1992;42:134–176 |
|
Silliman, 1999163
| • NIH Consensus Development Conference, 1990 | • NIH Consensus Conference. Treatment of
early-stage breast cancer. JAMA 1991;265:391–5 |
|
Solin, 1999164
| • NIH Consensus Development Conference, 1990 | • NIH Consensus Conference. Treatment of
early-stage breast cancer. JAMA 1991;265:391–5 |
|
Tyldesley, 2003165
| • NCI's physician Data Query treatment Options | • National Cancer Institute. CancerNet: A service
of the National Cancer Institute: PDQ Cancer Information
Summaries: Treatment. Monograph on line. Accessed September
2001. url: http://cancernet.nci.nih.gov/pdq/pdq_treatment.shtml. |
| • Cancer Care Ontario Clinical Practice
Guidelines | • Cancer Care Ontario Practice Guidelines
Initiative. Breast |
| • Clinical Practice Guidelines for the Care and
Treatment of Breast Cancer: A Canadian Consensus Document | • Cancer clinical practice guidelines. Monograph on
line. Accessed September 2001. url:http://hiru.mcmaster.ca/ccopgi/brecpg.html. |
| • NIH Consensus Conference on the Treatment of
Early Stage Breast Cancer | • Anonymous. Clinical practice guidelines for the
care and treatment of breast cancer: A Canadian consensus
document. Can Med Assoc J 1998;158(Suppl. 3):S1–S83. |
| • National Comprehensive Cancer Network Clinical
Practice Guidelines | • Anonymous. Early stage breast cancer—NIH
consensus conference. JAMA 1991;265:391–395. |
| • British Columbia Cancer Agency's Cancer
Management Manual | • Carlson RW, Goldstein LJ, Gradishar WJ, et al.
Update of the NCCN guidelines for treatment of breast cancer.
Oncology 1997;11:199–220. |
| • Diseases of the Breast | • British Columbia Cancer Agency. Cancer management
manual. Monograph on line. Accessed December 1999. url:
http://www.bccancer.bc.ca/pg_g_04.asp?PageID _
1109&Parent-ID _ 4/. |
| • American Colleges of Radiology, Surgery, and
Pathology's Standards for Breast Conservation Treatment | • Harris DM, Lippman ME, Morrow M, et al. Diseases
of the breast. 2nd ed. Philadelphia: Lippincott
Williams & Wilkins; 2000. |
| • American College of Radiology's Appropriateness
Criteria | • Winchester DP, Cox JD. Standards for breast
conservation treatment. Cancer 1992;42:134–163 |
| • Scottish Intercollegiate guidelines Network's
National Clinical Guidelines | • American College of Radiology Task Force on
Appropriateness Criteria. Appropriateness criteria for imaging
and treatment decisions in radiation oncology. Reston, VA:
American College of Radiology; 1999 |
| • UK Royal College of Radiology's Clinical Oncology
Information Network Guidelines | • Scottish Intercollegiate Guidelines Network.
Management of breast cancer. Monograph on line. Accessed
September 2001.url:http://www.show.scot.nhs.uk/sign/pdf/sign29.pdf
|
| • British Association of Surgical Oncology's
Symptomatic Breast Disease Guidelines | • Royal College of Radiologists Clinical Oncology
Information Network (COIN). Guidelines on the non-surgical
management of breast cancer. Monograph on line. Accessed
September 2001 url:http://www.rcr.ac.uk/breast.pdf. |
| | • BASO Breast Surgeons Group. The guidelines for
surgeons in the management of symptomatic breast disease. Eur J
Surg Oncol 1996;22:465–476 |
|
Wilkinson, 2003167
| • CAP guideline, 1998 | • Compton CC, Henson DE, Hammond EH et al.
Reporting on cancer specimens: protocols and case summaries.
Northfield, IL: College of American Pathologists; 1998 |